CN
CN
Our latest
Creative Biosciences
Lunsafe® Wins NMPA Approval, Pioneering Noninvasive Early Detection of Lung Cancer in China

Guangzhou, China – May 30, 2025 – Creative Biosciences (Guangzhou) CO., Ltd. today announced that its independently developed methylation test kit for the early detection of lung cancer, Lunsafe, has received official approval from China’s National Medic

Jun 01 , 2025
Media Coverage
Authoritative media releases


Read more
Press releases
Broadening Global Expansion: CreativeBio Draws Attention at ADLM 2024
May 27 , 2024
CreativeBio Revealed Over 170,000 Prospective Clinical Application Data of Colosafe®
Jun 06 , 2022
Creative Biosciences & Cooper Biosciences MENA Announce Partnership for the Commercialization of Colosafe® in the MENA region
Nov 23 , 2022
CreativeBio Major Announcement: Over 830,000 Real-World Application Test Cases of Colosafe® Released
May 27 , 2024
Creative Biosciences (Hong Kong) Co., Ltd Has Been Established - Rooted in the Greater Bay Area, Oriented Towards The Global Market.
Mar 07 , 2023
The Annual Gala and All-Staff Meeting Has Successfully Concluded: United in Strength, Let the Dragon Soaring Across the Five Continents
Dec 26 , 2023
Creative Biosciences (Guangzhou) and DKSH Enters into a Strategic Partnership to Lead Reducing Cancer Burden in Asia
Apr 23 , 2021
Clinical Utility of Colosafe®Is Once Again Proved Valuable！
Mar 17 , 2021
Top 100! Creative Biosciences Was Named "The First Guangzhou’s Top 100 Emerging Enterprises"
Dec 27 , 2023
CreativeBio has the greatest honor to resonate with “March Is Colorectal Cancer Awareness Month”
Mar 09 , 2021
2021 Happy Chinese New Year
Feb 01 , 2021
Happy 6th Birthday to Creative Biosciences!
Jan 14 , 2021

No. 10 Fenghuang Wu Road
Huangpu District
Guangzhou, Guangdong, 510555
P.R. China


Contact us at

T: +001-206-717-2769
Email: info@creativebio.cn


copyright ©2025 Creative Biosciences (Guangzhou) CO., Ltd
Legal mention